Exosome-associated lysophosphatidic acid signaling contributes to cancer pain

Pain associated with bone cancer remains poorly managed, and chemotherapeutic drugs used to treat cancer usually increase pain. The discovery of dual-acting drugs that reduce cancer and produce analgesia is an optimal approach. The mechanisms underlying bone cancer pain involve interactions between...

Descripción completa

Detalles Bibliográficos
Autores principales: Khasabova, Iryna A., Khasabov, Sergey G., Johns, Malcolm, Juliette, Joe, Zheng, Aunika, Morgan, Hannah, Flippen, Alyssa, Allen, Kaje, Golovko, Mikhail Y., Golovko, Svetlana A., Zhang, Wei, Marti, James, Cain, David, Seybold, Virginia S., Simone, Donald A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652716/
https://www.ncbi.nlm.nih.gov/pubmed/37278638
http://dx.doi.org/10.1097/j.pain.0000000000002967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652716/
https://www.ncbi.nlm.nih.gov/pubmed/37278638
http://dx.doi.org/10.1097/j.pain.0000000000002967

Ejemplares similares